Security key
31447P100
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)
CUSIP: 31447P100
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 34,474,972
- Total 13F shares
- 13,390,166
- Share change
- -247,629
- Total reported value
- $81,552,976
- Price per share
- $6.09
- Number of holders
- 68
- Value change
- -$1,522,792
- Number of buys
- 29
- Number of sells
- 22
Report period
Q1 2025
Institutions
68
Top holders
10
FENC full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
FENNEC PHARMACEUTICALS INC. SEC filings
FENNEC PHARMACEUTICALS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31447P100
Recent filing periods:
Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| DG Capital Management, LLC |
13F
13D/G
|
Company |
4.1%
from 13D/G
|
1,114,692
|
$7,044,853 | — | 31 Dec 2024 | |
| Southpoint Capital Advisors LP |
13F
|
Company |
12%
|
4,077,214
|
$25,767,992 | — | 31 Dec 2024 | |
| Sonic GP LLC |
13F
|
Company |
7%
|
2,407,357
|
$15,214,496 | — | 31 Dec 2024 | |
| Solas Capital Management, LLC |
13F
|
Company |
6.5%
|
2,250,919
|
$14,225,808 | — | 31 Dec 2024 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
3.7%
|
1,259,876
|
$7,962,416 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
3.6%
|
1,226,332
|
$7,750,418 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
969,754
|
$6,128,845 | — | 31 Dec 2024 | |
| HARBERT FUND ADVISORS, INC. |
13F
|
Company |
1.4%
|
466,869
|
$2,950,612 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
346,376
|
$2,189,097 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.99%
|
339,713
|
$2,146,986 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
303,090
|
$1,915,528 | — | 31 Dec 2024 | |
| Jeffrey L. Gendell |
13F
|
Individual |
0.58%
|
199,275
|
$1,259,418 | — | 31 Dec 2024 | |
| Lion Point Capital, LP |
13F
|
Company |
0.57%
|
195,700
|
$1,236,824 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.4%
|
136,755
|
$864,292 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.21%
|
71,197
|
$449,965 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
61,146
|
$386,443 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
52,128
|
$329,446 | — | 31 Dec 2024 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0.14%
|
49,848
|
$315,040 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.13%
|
44,626
|
$282,036 | — | 31 Dec 2024 | |
| Clayton Partners LLC |
13F
|
Company |
0.12%
|
40,540
|
$256,213 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.1%
|
35,827
|
$226,426 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.1%
|
35,672
|
$225,447 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.1%
|
34,299
|
$216,765 | — | 31 Dec 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.1%
|
34,000
|
$214,880 | — | 31 Dec 2024 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.08%
|
26,414
|
$166,936 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.08%
|
26,006
|
$164,358 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.06%
|
21,938
|
$138,648 | — | 31 Dec 2024 | |
| SHERBROOKE PARK ADVISERS LLC |
13F
|
Company |
0.06%
|
21,689
|
$137,074 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
18,626
|
$114,874 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.05%
|
15,886
|
$100,399 | — | 31 Dec 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.05%
|
15,676
|
$99,072 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
15,522
|
$98,099 | — | 31 Dec 2024 | |
| Pinnacle Wealth Planning Services, Inc. |
13F
|
Company |
0.04%
|
15,388
|
$97,252 | — | 31 Dec 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.04%
|
13,442
|
$84,953 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
13,152
|
$83,121 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
12,432
|
$78,570 | — | 31 Dec 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.03%
|
11,653
|
$73,647 | — | 31 Dec 2024 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.03%
|
10,988
|
$69,444 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
10,769
|
$68,060 | — | 31 Dec 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.03%
|
9,753
|
$61,639 | — | 31 Dec 2024 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0.02%
|
6,950
|
$43,924 | — | 31 Dec 2024 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0.02%
|
6,250
|
$39,500 | — | 31 Dec 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
4,672
|
$29,000 | — | 31 Dec 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
2,451
|
$15,540 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,196
|
$13,879 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.01%
|
2,040
|
$12,893 | — | 31 Dec 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
1,698
|
$10,731 | — | 31 Dec 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
1,565
|
$9,515 | — | 31 Dec 2024 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
1,499
|
$9,474 | — | 31 Dec 2024 | |
| State of Wyoming |
13F
|
Company |
0%
|
1,139
|
$7,198 | — | 31 Dec 2024 |
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) as of Q1 2025
As of 31 Mar 2025,
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,390,166 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Solas Capital Management, LLC, Rosalind Advisors, Inc., BlackRock, Inc., VANGUARD GROUP INC, HARBERT FUND ADVISORS, INC., AIGH Capital Management LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY.
This page lists
68
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
64
Q1 2025 holders
68
Holder diff
4
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.